Open Access2020 ESC Guidelines for the diagnosis and management of atrial fibrillation: what is new for neurologists?
Author(s) -
С. Н. Янишевский,
Я. Б. Скиба,
А. Ю. Полушин
Publication year - 2021
Publication title -
arterialʹnaâ gipertenziâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.126
H-Index - 5
eISSN - 2411-8524
pISSN - 1607-419X
DOI - 10.18705/1607-419x-2021-27-1-7-15
Subject(s) - antithrombotic , medicine , atrial fibrillation , clinical practice , anticoagulant therapy , stroke (engine) , intensive care medicine , position paper , anticoagulant , management of atrial fibrillation , cardiology , physical therapy , pathology , mechanical engineering , engineering
Clinical practice guidelines for the diagnosis and management of atrial fibrillation (AF) are one of the most regularly updated documents by the European Society of Cardiology. The new version of clinical practice guidelines (2020) contains a number of changes regarding anticoagulant therapy in patients with AF who have developed acute cerebrovascular accidents. In this review, we discuss the statements of the updated document on the timing of the start/restart of anticoagulant therapy after ischemic stroke and intracranial hemorrhage in patients with AF, the choice of antithrombotic therapy in patients with cryptogenic stroke, as well as the need for the additional testing to clarify the origin of the embolism. We provide our original position on the possibility of applying these recommendations to the real clinical practice.